Savient Pharmaceuticals (SVNT) Posts Q1 Loss of 34c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as climbing oil, yields amplify inflation fears
- Oil jumps 5%, then pares gains after Trump says no attack on Iran this month
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- CoreWeave stock drops on dilution fears and debt concerns
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
William Blair Downgrades Savient Pharmaceuticals (SVNT) to Market Perform
May 17, 2013 6:47 AM EDTWilliam Blair downgraded Savient Pharmaceuticals (NASDAQ: SVNT) from Outperform to Market Perform with a price target of $1.00 (from $2.00).
For an analyst ratings summary and ratings history on Savient Pharmaceuticals click here. For more ratings... More



